Tyra Biosciences, Inc. (TYRA)
20.39
+0.15
(+0.74%)
USD |
NASDAQ |
Oct 07, 16:00
19.89
-0.50
(-2.45%)
After-Hours: 07:24
Tyra Biosciences Total Assets (Quarterly) : 383.36M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 383.36M |
| March 31, 2026 | 412.04M |
| December 31, 2025 | 284.05M |
| September 30, 2025 | 301.85M |
| June 30, 2025 | 321.50M |
| March 31, 2025 | 343.48M |
| December 31, 2024 | 365.10M |
| September 30, 2024 | 380.59M |
| June 30, 2024 | 392.46M |
| March 31, 2024 | 404.74M |
| December 31, 2023 | 225.86M |
| September 30, 2023 | 238.36M |
| Date | Value |
|---|---|
| June 30, 2023 | 250.01M |
| March 31, 2023 | 255.06M |
| December 31, 2022 | 266.18M |
| September 30, 2022 | 275.98M |
| June 30, 2022 | 287.12M |
| March 31, 2022 | 298.97M |
| December 31, 2021 | 306.96M |
| September 30, 2021 | 315.97M |
| June 30, 2021 | |
| March 31, 2021 | 141.81M |
| December 31, 2020 | 16.01M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 29.70M |
| Shareholders Equity (Quarterly) | 353.66M |
| Debt to Equity Ratio | 0.0158 |
| Current Ratio | 14.91 |
| Net Debt Paydown Yield | 0.01% |